OC-0604 Early toxicity after SABR of oligometastatic bony metastases in the BONY M phase II trial

Autor: Spindler, N.J., Felter, M.V.O., Hansen, O., Nielsen, T.B., Suppli, M.H., Josipovic, M., Poulsen, L.Ø., Gaard-Petersen, F., Sand, H.M.B., Abramova, T.M., Johansen, M., Kornerup, J.S., Alsaker, M.D., Serup-Hansen, E., Geertsen, P., Vogelius, I.R., Behrens, C., Persson, G.F.
Zdroj: In Radiotherapy and Oncology May 2022 170 Supplement 1:S529-S530
Databáze: ScienceDirect